Investment analysts at StockNews.com initiated coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a report released on Tuesday. The firm set a “sell” rating on the stock. MBRX has been the topic of a number of other reports. Oppenheimer reiterated an “outperform” rating and set a $5.00 target price on shares of […]
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a report released on Monday. The brokerage issued a sell rating on the stock. MBRX has been the topic of a number of other research reports. Oppenheimer reaffirmed an outperform rating and set a $5.00 price objective on shares of Moleculin Biotech […]
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a research report report published on Sunday. The brokerage issued a sell rating on the stock. MBRX has been the subject of a number of other reports. Roth Mkm reaffirmed a buy rating and set a $16.00 price target on shares of […]
StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a research report report published on Sunday morning. The firm issued a sell rating on the stock. A number of other brokerages also recently issued reports on MBRX. Roth Mkm reiterated a buy rating and issued a $16.00 price target on shares […]